AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

STERIS (STE)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

219.76

0.42 (0.19%)

At close: Feb 18, 2025, 3:59 PM

219.66

-0.05%

After-hours: Feb 18, 2025, 04:11 PM EST

undefined% (undefined)

Bid	197.32
Market Cap	21.59B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	6.23
PE Ratio (ttm)	35.27
Forward PE	n/a
Analyst	Buy

Ask	242
Volume	193,087
Avg. Volume (20D)	530,094
Open	217.54
Previous Close	219.34
Day's Range	214.81 - 220.29
52-Week Range	197.82 - 248.24
Beta	undefined

About STE

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capit...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Jun 1, 1992

Employees 18,000

Stock Exchange NYSE

Ticker Symbol STE

Website https://www.steris.com

Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for STE stock is "Buy." The 12-month stock price forecast is $265, which is an increase of 20.59% from the latest price.

Buy 80.00%

Hold 20.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

STERIS is scheduled to release its earnings on May 7, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 weeks ago

+3.55%

STERIS shares are trading higher. The company anno... Unlock content with Pro Subscription

3 months ago

-5.28%

Steris shares are trading lower after the company reported worse-than-expected Q2 revenue results

News

1 week ago · zacks.com

Steris (STE) International Revenue in Focus: Trends and Expectations

Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

1 week ago · seekingalpha.com

STERIS plc (STE) Q3 2025 Earnings Call Transcript

STERIS plc (NYSE:STE ) Q3 2025 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Julie Winter – Investor Relations Mike Tokich – Senior Vice President and Chief Financial Offic...

1 week ago · zacks.com

STE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket

STERIS' third-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues. The lowered revenue guidance for fiscal 2025 is concerning.

2 weeks ago · zacks.com

Steris (STE) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street...

2 weeks ago · zacks.com

Steris (STE) Matches Q3 Earnings Estimates

Steris (STE) came out with quarterly earnings of $2.32 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $2.22 per share a year ago.

2 weeks ago · reuters.com

Steris lowers annual profit forecast due to a stronger dollar

Medical equipment maker Steris lowered its annual profit forecast on Wednesday, citing the impact of a stronger dollar.

2 weeks ago · zacks.com

Can Steris (STE) Keep the Earnings Surprise Streak Alive?

Steris (STE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 weeks ago · zacks.com

Can These 5 MedTech Stocks Hit Earnings Targets This Season?

Here is a sneak peek into how five MedTech stocks, BSX, HOLX, TECH, STE and ALGN, are expected to fare in their quarterly results, slated to be released tomorrow.

2 weeks ago · zacks.com

Wall Street's Insights Into Key Metrics Ahead of Steris (STE) Q3 Earnings

Get a deeper insight into the potential performance of Steris (STE) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for som...

2 weeks ago · zacks.com

STE Gears Up for Q3 Earnings: Here's What You Need to Know

STERIS' third-quarter fiscal 2025 results are likely to reflect the positives of normalizing the Healthcare backlog and increasing bioprocessing demand.

Load More News